Contact
Header_1077x260px_About_Profil.jpg

A novel long-acting Amylin analogue for the management of obesity

Pharmacological options for weight management and people with T2D

A pathophysiological update of the incretins

Once-weekly basal insulin analogue in clinical development

Dual-hormone artificial pancreas systems

New strategies for the treatment of obesity and metabolic dysfunctions

Targeting the incretin/glucagon system: a glimmer of hope

Pancreatic ß-cell function changes in response to pharmacological or life-style interventions

Can a dual-hormone closed loop delivery systems become a “technical cure” of diabetes?

Smart Insulin Patches or Glucose-Responsive Insulin Delivery Systems